Search
Selected: I

Inhibition of excessive phospholipase A.sub.2 activity and/or pr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Inhibition of excessive phospholipase A.sub.2 activity and/or pr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Inhibition of mammalian collagenolytic enzymes by tetracyclines

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Inhibition of wasting and protein degradation of mammalian muscl

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Inhibitor of cataract formation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Injection solution for intramuscular and subcutaneous administra

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.